Evidence map›Paper›PMID 28290130›Full record

SynthesisInfection2017

The "Choosing Wisely" initiative in infectious diseases.

Clara Lehmann, Reinhard Berner, Johannes R Bogner, Oliver A Cornely, Katja de With, Susanne Herold, Winfried V Kern, Sebastian Lemmen, Mathias W Pletz, Bernhard Ruf and 6 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

Clara LehmannDepartment I of Internal Medicine, University of Cologne, Cologne, Germany. clara.lehmann@uni-koeln.de.ORCID http://orcid.org/0000-0002-7042-1578
Reinhard BernerDepartment of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Johannes R BognerDepartment of Infectious Diseases, Med Klinik IV, University Hospital Munich, Munich, Germany.
Oliver A CornelyDepartment I of Internal Medicine, University of Cologne, Cologne, Germany.
Katja de WithClinical Infectious Diseases and Antibiotic Stewardship Unit, Carl Carus University Hospital, Dresden, Germany.
Susanne HeroldDepartment of Internal Medicine II, University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.
Winfried V KernDivision of Infectious Diseases, Department of Medicine, Albert-Ludwigs-University Hospital and Medical Center, Freiburg, Germany.
Sebastian LemmenDivision of Infection Control and Infectious Diseases, University Hospital RWTH Aachen, Aachen, Germany.
Mathias W PletzCenter for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Bernhard RufDivision of Infectious Diseases and Tropical Medicine, Klinikum Sankt Georg, Leipzig, Germany.
Bernd SalzbergerDepartment of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany.
Hans Jürgen StellbrinkInfectiology Center Hamburg (ICH), Hamburg, Germany.
Norbert SuttorpDepartment of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Andrew J UllmannDivision of Infectious Diseases, Department of Internal Medicine II, Universitätsklinikum, Julius Maximilian's University, Würzburg, Germany.
Gerd FätkenheuerDepartment I of Internal Medicine, University of Cologne, Cologne, Germany.
Norma JungDepartment I of Internal Medicine, University of Cologne, Cologne, Germany.
University of Cologne · DECharité - Universitätsmedizin Berlin · DEInfektionsmedizinisches Centrum Hamburg · DEJena University Hospital · DEJustus-Liebig-Universität Gießen · DEKlinikum St. Georg · DEMünchen Klinik · DERWTH Aachen University · DETH Köln - University of Applied Sciences · DEUniversity Hospital Carl Gustav Carus · DEUniversity Hospital Regensburg · DEUniversity Medical Center Freiburg · DE

Funding

Role of LUBAC and Na K-ATPase in Acute Lung InjuryP01HL071643 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SZNAJDER, JACOB I · 2003 to 2019
$30.8M
NHLBI NIH HHS P01 HL071643
6 · The paper itself

Abstract

objective"Choosing Wisely" is a growing international campaign aiming at practice changes to improve patient health and safety by both, conduct of essential and avoidance of unnecessary diagnostic, preventive and therapeutic procedures. The goal is to create an easily recognizable and distributable list ("Choosing Wisely items") that addresses common over- and underuse in the management of infectious diseases.

methodsThe German Society of Infectious Diseases (DGI) participates in the campaign "Klug Entscheiden" by the German Society of Internal Medicine. Committee members of the (DGI) listed potential 'Choosing Wisely items'. Topics were subjected to systematic evidence review and top ten items were selected for appropriateness. Five positive and negative recommendations were approved via individual member vote.

resultsThe final recommendations are: (1) Imperatively start antimicrobial treatment and remove the focus in Staphylococcus aureus bloodstream infection. (2) Critically ill patients with signs of infection need early appropriate antibiotic therapy. (3) Annual influenza vaccination should be given to individuals with age >60 years, patients with specific co-morbidities and to contact persons who may spread influenza to others. (4) All children should receive measles vaccine. (5) Prefer oral formulations of highly bioavailable antimicrobials whenever possible. (6) Avoid prescribing antibiotics for uncomplicated upper respiratory tract infections. (7) Do not treat asymptomatic bacteriuria with antibiotics. (8) Do not treat Candida detected in respiratory or gastrointestinal tract specimens. (9) Do not prolong prophylactic administration of antibiotics in patients after they have left the operating room. (10) Do not treat an elevated C-reactive protein (CRP) or procalcitonin with antibiotics for patients without signs of infection.

conclusionsPhysicians will reduce potential harm to patients and increase the value of health care when implementing these recommendations.

Indexed as

Global HealthHealth PromotionCommunicable DiseasesDelivery of Health CareGermanyHumansPublic HealthUnnecessary ProceduresChoosing WiselyInfectious diseasesRecommendations

Identifiers

PMID28290130
OpenAlexW2139119327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.